Herceptin triples breast cancer patients’ chance of survival

London, Sept 26 : A new study has revealed that women with advanced breast cancer can live longer by taking the drug Herceptin, even after they have suffered a relapse.

The finding is based on data from the Hermine trial, an observational study involving 340 women with advanced HER2-positive breast cancer.

Herceptin is the only HER2-targeted therapy proven to extend lives in both early and advanced stages of the disease.

MRI may eliminate the need for biopsies to identify breast cancer

Washington, Sept 26 : According to a study focused on non-mass enhancing breast lesions, Proton magnetic resonance spectroscopy (¹H MRS) used in conjunction with magnetic resonance imaging (MRI) can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies.

The study, conducted at Memorial Sloan-Kettering Cancer Centre in New York, is published in the October issue of the journal Radiology.

Amritsar kids observe Bhagat Singh's 100th birth anniversary a day earlier

Amritsar, Sept.26 :Children of the Ram Ashram School in Amritsar today celebrated the 100th birth anniversary of freedom fighter Bhagat Singh, a day earlier than scheduled.

Holding placards and photographs of Bhagat Singh during the felicitation ceremony, the children inspired a feeling of patriotism through the gathering.

Harkirat Singh, a student, dressed up like Bhagat Singh for the occasion.

New multi-focal lenses may help restore vision to cataract patients

Washington, September 26 : An ophthalmologist at Weill Cornell Medical College has said that restoring vision to cataract patients may be possible by implanting them with the newly developed multi-focal lenses.

“There are no alternatives to surgery, but there are new advances to the restoration process. We have lenses that will allow you to see at a distance as well as read without glasses. There are lenses that can correct astigmatisms. The options have become much-improved in the past couple of years,” said Dr. Calvin Roberts.

Cricket(ers) takes a ‘back seat’ at Wankhede

Mumbai, Sept 26 : It was a ceremony meant to facilitate Team India for winning the Twenty20 World Championship, but cricket virtually took a ‘back seat’ at the Wankhede Stadium here today, as no cricketer except skipper Mahendra Singh Dhoni was given a seat in the front row at the dais.

At the event, organised to celebrate a purely sporting achievement, the first row on the stage was dominated by politicians and officials of the Board of Control for Cricket (BCCI), even as the hoarding in the background ‘loudly’ said “Congratulations Team India.”

Israeli, Jordanian scientists grow artificial reefs to heal natural ones

Washington, Sept 26 : Israeli and Jordanian scientists have constructed a string of artificial coral reefs in the Red Sea with the aim of weaning away divers and snorkelers from natural reefs, allowing them time to heal.

A high diversity of corals thrive in the Gulf of Aqaba, which lies at the northern end of the Red Sea and is bordered by Israel and Jordan, and Egypt and Saudia Arabia farther south.

These reefs draw tourists from around the world to the neigh boring resort cities of Elat, Israel, and Al 'Aqabah, Jordan.

Pages

News in Focus

M&M Financial Services Share Price Target at Rs 350: IDBI Capital

IDBI Capital has maintained a BUY rating on M&M Financial Services (MMFS), with a target price of Rs 350, implying a potential upside of ~19% from the current market price of Rs 294.

Axis Bank Share Price Target at Rs 1,610: Anand Rathi Research

Anand Rathi Share and Stock Brokers has reiterated a BUY rating on Axis Bank, setting a 12-month target price of Rs1,610, implying a meaningful upside from the cur

Reliance Industries Share Price Target at Rs 1,610: BOB Capital Markets

Reliance Industries continues to command analyst confidence, even as near-term pressures emerge in select business segments.

IDFC First Bank Share Price Target at Rs 82: Axis Securities

Axis Securities has reiterated a BUY call on IDFC First Bank Ltd., setting a revised target price of Rs 82 per share, implying an upside of nearly 22% from current levels.

Why a DSLR Camera Is Still the Best Upgrade You Can Make in 2026

Phone cameras are good, but a DSLR is in a different league. Here are five reasons why 2026 is a great time to invest in one and how to buy it on Easy EMIs with Bajaj Finserv.